Patents by Inventor Lauren M. B. Luhrs

Lauren M. B. Luhrs has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
    Patent number: 10251865
    Abstract: Disclosed herein is a method of upregulating regulatory T-cells, and treating diseases that would benefit from such upregulation, by administering an alpha-2 receptor agonist.
    Type: Grant
    Filed: November 15, 2017
    Date of Patent: April 9, 2019
    Assignee: ALLERGAN, INC.
    Inventors: Daniel W. Gil, John E. Donello, Veena Viswanath, Lauren M. B. Luhrs
  • METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS
    Publication number: 20180071259
    Abstract: Disclosed herein is a method of upregulating regulatory T-cells, and treating diseases that would benefit from such upregulation, by administering an alpha-2 receptor agonist.
    Type: Application
    Filed: November 15, 2017
    Publication date: March 15, 2018
    Inventors: Daniel W. Gil, John E. Donello, Veena Viswanath, Lauren M.B. Luhrs
  • METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS
    Publication number: 20170079956
    Abstract: Disclosed herein is a method of upregulating regulatory T cells, and treating diseases that would benefit from such upregulation, by administering an alpha-2 receptor agonist.
    Type: Application
    Filed: December 7, 2016
    Publication date: March 23, 2017
    Inventors: Daniel W. Gil, John E. Donello, Veena Viswanath, Lauren M.B. Luhrs
  • Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
    Patent number: 9545394
    Abstract: Disclosed herein is a method of upregulating regulatory T cells, and treating diseases that would benefit from such upregulation, by administering an alpha-2 receptor agonist.
    Type: Grant
    Filed: February 12, 2016
    Date of Patent: January 17, 2017
    Assignee: Allergan, Inc.
    Inventors: Daniel W. Gil, John E. Donello, Veena Viswanath, Lauren M. B. Luhrs
  • METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS
    Publication number: 20160158199
    Abstract: Disclosed herein is a method of upregulating regulatory T-cells, and treating diseases that would benefit from such upregulation, by administering an alpha-2 receptor agonist.
    Type: Application
    Filed: February 12, 2016
    Publication date: June 9, 2016
    Inventors: Daniel W. Gil, John E. Donello, Veena Viswanath, Lauren M.B. Luhrs
  • Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
    Patent number: 9289420
    Abstract: Disclosed herein is a method of upregulating regulatory T-cells, and treating diseases that would benefit from such upregulation, by administering an alpha-2 receptor agonist.
    Type: Grant
    Filed: November 4, 2013
    Date of Patent: March 22, 2016
    Assignee: Allergan, Inc.
    Inventors: Daniel W. Gil, John E. Donello, Veena Viswanath, Lauren M. B. Luhrs
  • METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS
    Publication number: 20140066483
    Abstract: Disclosed herein is a method of upregulating regulatory T-cells, and treating diseases that would benefit from such upregulation, by administering an alpha 2 receptor agonist.
    Type: Application
    Filed: November 4, 2013
    Publication date: March 6, 2014
    Applicant: Allergan, Inc.
    Inventors: Daniel W. Gil, John E. Donello, Veena Viswanath, Lauren M.B. Luhrs
  • Method of activating regulatory T cells with alpha-2B adrenergic receptor agonists
    Patent number: 8575207
    Abstract: Disclosed herein is a method of upregulating regulatory T-cells, and treating diseases that would benefit from such upregulation, by administering an alpha 2 receptor agonist.
    Type: Grant
    Filed: August 11, 2011
    Date of Patent: November 5, 2013
    Assignee: Allergan, Inc.
    Inventors: Daniel W. Gil, John E. Donello, Veena Viswanath, Lauren M. B. Luhrs
  • Method of treating sensorimotor disorders with alpha-2 adrenergic receptor agonists
    Patent number: 8455548
    Abstract: Disclosed herein is a method of treating sensorimotor disorders comprising administering to a subject in need of such treatment an alpha-2 receptor agonist lacking significant alpha-2A receptor activity.
    Type: Grant
    Filed: October 14, 2008
    Date of Patent: June 4, 2013
    Assignee: Allergan, Inc.
    Inventors: Lauren M. B. Luhrs, Daniel W. Gil, John E. Donello
  • Compositions and methods for treating seizure disorders
    Patent number: 8404721
    Abstract: Disclosed are methods of treating a seizure disorder by administering to a patient in need of such treatment a compound having the following formula:
    Type: Grant
    Filed: July 10, 2012
    Date of Patent: March 26, 2013
    Assignee: Allergan, Inc.
    Inventors: John E. Donello, Lauren M. B. Luhrs
  • COMPOSITIONS AND METHODS FOR TREATING SEIZURE DISORDERS
    Publication number: 20120295936
    Abstract: Disclosed are methods of treating a seizure disorder by administering to a patient in need of such treatment a compound having the following formula:
    Type: Application
    Filed: July 10, 2012
    Publication date: November 22, 2012
    Applicant: ALLERGAN, INC.
    Inventors: John E. Donello, Lauren M.B. Luhrs
  • Compositions and methods for treating seizure disorders
    Patent number: 8242141
    Abstract: Disclosed are methods of treating a seizure disorder by administering to a patient in need of such treatment a compound having the following formula:
    Type: Grant
    Filed: September 15, 2010
    Date of Patent: August 14, 2012
    Assignee: Allergan, Inc.
    Inventors: John E. Donello, Lauren M. B. Luhrs
  • METHODS OF TREATING MOTOR DISORDERS WITH ALPHA-2B ANDRENERGIC RECEPTOR AGONISTS
    Publication number: 20120190719
    Abstract: Disclosed herein is a method of treating compulsive disorders comprising administering to a subject in need of such treatment an alpha-2 receptor agonist.
    Type: Application
    Filed: August 26, 2010
    Publication date: July 26, 2012
    Applicant: ALLERGAN, INC.
    Inventors: Daniel W. Gil, John E. Donello, Lauren M.B. Luhrs
  • Methods for treating anxiety
    Patent number: 8211917
    Abstract: Disclosed are methods of treating anxiety by administering to a patient in need of such treatment a compound having the following formula (I).
    Type: Grant
    Filed: July 8, 2008
    Date of Patent: July 3, 2012
    Assignee: Allergan, Inc.
    Inventors: John E. Donello, Lauren M. B. Luhrs
  • METHOD OF ACTIVATING REGULATORY T CELLS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS
    Publication number: 20120041031
    Abstract: Disclosed herein is a method of upregulating regulatory T-cells, and treating diseases that would benefit from such upregulation, by administering an alpha 2 receptor agonist.
    Type: Application
    Filed: August 11, 2011
    Publication date: February 16, 2012
    Applicant: ALLERGAN, INC
    Inventors: Daniel W. Gil, John E. Donello, Veena Viswanath, Lauren M.B. Luhrs
  • METHOD OF TREATING SENSORIMOTOR DISORDERS WITH 4-(1-(2,3-DIMETHYLPHENYL)ETHYL)-1H-IMIDAZOLE-2(3H)-THIONE
    Publication number: 20110269805
    Abstract: Disclosed herein is a method of treating sensorimotor disorders comprising administering to a subject in need of such treatment 4-(1-(2,3-dimethylphenyl)ethyl)-1H-imidazole-2(3H)-thione.
    Type: Application
    Filed: October 14, 2008
    Publication date: November 3, 2011
    Inventors: Daniel W. Gil, John E. Donello, Lauren M.B. Luhrs
  • METHOD OF TREATING MOTOR DISORDERS WITH ALPHA-2B ADRENERGIC RECEPTOR AGONISTS
    Publication number: 20110160265
    Abstract: Disclosed herein is a method of treating motor disorders comprising administering to a subject in need of such treatment an alpha-2 receptor agonist lacking significant alpha-2A receptor activity.
    Type: Application
    Filed: October 14, 2008
    Publication date: June 30, 2011
    Inventors: Lauren M.B. Luhrs, Daniel W. Gil, John E. Donello
  • COMPOSITIONS AND METHODS FOR TREATING SEIZURE DISORDERS
    Publication number: 20110065747
    Abstract: Disclosed are methods of treating a seizure disorder by administering to a patient in need of such treatment a compound having the following formula:
    Type: Application
    Filed: September 15, 2010
    Publication date: March 17, 2011
    Inventors: John E. Donello, Lauren M.B. Luhrs
  • METHOD OF TREATING SENSORIMOTOR DISORDERS WITH ALPHA-2 ADRENERGIC RECEPTOR AGONISTS
    Publication number: 20100240699
    Abstract: Disclosed herein is a method of treating sensorimotor disorders comprising administering to a subject in need of such treatment an alpha-2 receptor agonist lacking significant alpha-2A receptor activity.
    Type: Application
    Filed: October 14, 2008
    Publication date: September 23, 2010
    Inventors: Lauren M.B. Luhrs, Daniel W. Gil, John E. Donello
  • METHOD OF TREATING MOTOR DISORDERS WITH 4-(1-(2,3-DIMETHYLPHENYL)ETHYL)-1H-IMIDAZOLE-2(3H)-THIONE
    Publication number: 20100216857
    Abstract: Disclosed herein is a method of treating motor disorders comprising administering to a subject in need of such treatment 4-(1-(2,3-dimethylphenyl)ethyl)-1H-imidazole-2(3H)-thione.
    Type: Application
    Filed: October 14, 2008
    Publication date: August 26, 2010
    Inventors: Lauren M.B. Luhrs, Daniel W. Gil, John E. Donello